City
Epaper

Amid vaccine certification issue, National Health Authority CEO calls for deepening India-UK health ties

By ANI | Published: September 23, 2021 7:59 PM

After meeting British High Commissioner to India Alex Ellis here, National Health Authority's CEO Dr RS Sharma has said that he looks forward to deepening ties between the health bodies of the two countries.

Open in App

After meeting British High Commissioner to India Alex Ellis here, National Health Authority's CEO Dr RS Sharma on Thursday said that he looks forward to deepening ties between the health bodies of the two countries.

The meeting came amid the rising concerns over the new travel rules issued by the UK.

Dr Sharma said that the meeting will be instrumental in resuming socio-economic ties between the two countries.

"Echoing his excellency @AlexWEllis's views, this will be instrumental in resuming socio-economic activities between India and UK. We also look forward to deepening ties between @AyushmanNHA and @NHSX, as we collaborate to build a digital continuum of healthcare services," Dr Sharma said in a tweet.

Earlier, Ellis said the "excellent discussions" were an important step forward in "our joint aim to facilitate travel and fully protect the public health of UK and India".

"Excellent technical discussions with @rssharma3 @AyushmanNHA. Neither side raised technical concerns with each other's certification process. An important step forward in our joint aim to facilitate travel and fully protect public health of UK and India," Ellis tweeted.

The UK issued a revised travel advisory on Wednesday and said that Covishield is qualified as an approved vaccine.

It approved individuals with a full course of the Oxford-AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from a relevant public health body in Australia, Antigua and Barbuda, Barbados, Bahrain, Brunei, Canada, Dominica, Israel, Japan, Kuwait, Malaysia, New Zealand, Qatar, Saudi Arabia, Singapore, South Korea or Taiwan. But the list does not include India. This advisory will be applicable from 4 am (local time) on October 4.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: National Health AuthorityPfizerAyushman national health authorityPfizer inc.Pfizer india
Open in App

Related Stories

InternationalFormer Pfizer Employee, Indian-American, Found Guilty of Insider Trading on Covid Medicine Trial in the US

InternationalEx-Pfizer employee, accomplice from India charged with insider trading in US

BusinessFormer Pfizer employee charged with insider trading

HealthStudy finds cancer cells can adapt to novel drugs

HealthUS likely to see shortage of antibiotics for children, adults: Report

International Realted Stories

InternationalBiden condemns anti-Semitism, promises to support Israel

International"Assault on Rafah would be strategic mistake": UN Chief Guterres

InternationalTrump's classified documents trial postponed indefinitely

InternationalTikTok sues US govt to block potential ban

InternationalHamas, Israeli negotiators arrive in Cairo for Gaza ceasefire talks